Early detection of autism spectrum disorder is vital for giving children the best start in life, but diagnosis is often delayed due to lengthy and resource-intensive assessments.
Single B cell screening is revolutionising precision medicine by enabling faster discovery of personalised, highly targeted antibody treatments and diagnostics.
Clinicians are increasingly interested in using routine screening for ACEs in paediatric/primary-care settings to mitigate the health effects of ACEs in children and adults.